Credit: ImmunityBio. Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in ...

Clinically significant improvement seen in fatigue, and improvement seen in relative peak aerobic capacity with 12-week exercise regimen. (HealthDay News) — For patients with advanced prostate ...

IRH linked to incident heart failure, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction. (HealthDay News) — Infection-related hospitalization (IRH) is ...

Although low-dose dapagliflozin was less effective in preventing hospitalization for heart failure, SGLT-2 inhibitors had similar cardiovascular outcomes in T2D. Canagliflozin and dapagliflozin ...

Lower likelihood seen for experiencing increase in Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (HealthDay News) — For patients with ...

Despite major changes in the prevalence of antibiotic resistance, the 2011 IDSA guideline for uncomplicated UTI still accurately reflects the efficacy and safety of first-line treatments.

Recent study is the first to show improved survival of patients on dialysis whose kidney failure is due to kidney stones vs other causes Kidney stone-related kidney failure (KF) is associated with ...

Survey reveals employees do not always prioritize their health over work. (HealthDay News) — Chronic health conditions are taking a toll on the US workforce’s lives and productivity, according ...

Kidney stones and gallstones may increase the risk for prostate cancer, which could have implications for disease monitoring and prevention in specific populations. Patients with kidney stones or ...

Merilog administered subcutaneously 5 to 10 minutes before mealtime helps improve glycemic control. (HealthDay News) — The US Food and Drug Administration has approved Merilog (insulin-aspart ...

In 2023, 35.6% of patients received androgen-deprivation therapy alone. Real-world data suggest that, although guideline-concordant care is on the rise, many US patients with metastatic hormone ...

Platelet level may indicate response to 177Lu PSMA therapy in radium-223 treated patients with mCRPC. Lutetium-177-PSMA-617 (177 Lu PSMA) appears effective following treatment with radium 223 (223 ...